Introduction
Coronary heart disease is thought to be associated with a generalized atherosclerotic process that begins in the large arteries (1) . The Rotterdam study, which included over 3,000 elderly subjects, showed that arterial stiffness was strongly related to atherosclerosis at various sites in the vascular tree (2) . In addition, many studies have reported an association between elevated arterial stiffness and coronary heart disease (3) (4) (5) (6) (7) (8) , and increased arterial stiffness may contribute to the age-related increase in incidence of cardiovascular disease the measurement of brachial-ankle PWV using pressure cuffs wrapped around the brachium and ankle. The validity and reproducibility of this new technique have been assessed by means of Pearson's correlation analysis and Bland-Altman plotting (17) (18) (19) , and it has been suggested that the automatic non-invasive device has good potential as a device for screening subclinical vascular pathology (20) . However, to the best of our knowledge, the predictive value of arterial stiffness measured through brachial-ankle PWV in the presence or absence of coronary artery disease (CAD) has not previously been established. Furthermore, there have been few direct analyses of the association between brachial-ankle PWV and the presence of CAD as evaluated by coronary angiography (21, 22) .
Thus, the aims of the present cross-sectional study were to examine the relationship between aortic stiffness measured through brachial-ankle PWV and the presence or absence of CAD, and to advance the hypothesis that brachial-ankle PWV can be used as a predictor of CAD.
Methods

Study Subjects
One hundred and twenty-three consecutive patients (77 males, 46 females; mean age, 63.5 11.8 years; range, 21 to 90 years) were enrolled in this study. All subjects received coronary angiographic examination at the Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Nagasaki University between April 2000 and January 2001. The protocol of this study was approved by the locally appointed ethics committee, the procedures were in compliance with the Declaration of Helsinki, and all subjects gave their informed consent to participate. The clinical diagnoses were as follows: chest pain and/or ischemic heart disease (IHD), including effort, resting angina, and acute coronary syndrome (n 75 patients), mitral valve heart disease (n 24), cardiomyopathy (n 20: 10 with dilated cardiomyopathy and 10 with hypertrophic cardiomyopathy), and congenital heart disease (n 4). Patients who previously underwent coronary intervention were excluded from this study, because coronary intervention changes the degree and time course of coronary artery stenosis. Patients with aortic valve heart disease, aortic aneurysm, arteriosclerosis obliterans (ankle brachial index <0.9), and low left ventricular ejection fraction (<30%) were also excluded, because these conditions can affect brachial-ankle PWV independent of ischemic status.
Measurement of Cardiovascular Risk Factors
Cardiovascular risk factors, including systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure, heart rate, total cholesterol, and plasma glucose were measured in all subjects. Fifty-six subjects (34 males, 22 females) were classified as having hypertension, defined as SBP >140 mmHg and/or DBP >90 mmHg or use of antihypertensive drugs. Forty-four subjects (29 males, 15 females) were diagnosed with hyperlipidemia, and 33 subjects (22 males, 11 females) were diagnosed with diabetes mellitus. Hyperlipidemia was defined as a total cholesterol over 220 mg/dl or use of lipid-lowering agents (statins or fibrates). Diabetes mellitus was defined as a fasting glycemia over 7.8 mmol/l or use of hypoglycemic agents (insulin, sulfamids, and/or biguanids). Smoking status was defined according to current use. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m 2 ). To clarify whether the drug treatment had an influence on brachial-ankle PWV, we investigated the drug regimens of patients divided according to the presence or absence of CAD.
Measurement of PWV Values
PWV was determined using an automatic volume-plethysmographic device, form PWV/ABI (Colin Co., Komaki, Japan). Occlusion and monitoring cuffs were placed around both sides of the upper and lower extremities, and pressure waveforms of the brachial and tibial arteries were recorded. Heart sounds S1 and S2 were detected by a microphone set on the left edge of the sternum at the fourth intercostal space. The time interval between the brachium and ankle (∆Tba) was defined as the time interval between the wave front of the brachial waveform and that of the ankle waveform. The sampling time was 10 s with automatic gain analysis and quality adjustment. The distance between sampling points of brachial-ankle PWV was calculated automatically according to the height of the subject. The path length from the suprasternal notch to the brachium (Lb) and ankle (La) was expressed using the following equation: Lb 0.2195 height of the patient (in cm) 2.0734, La 0.8129 height of the patient (in cm) 12.328. The following equation was used to obtain brachial-ankle PWV: brachial ankle PWV (Lb La)/ ∆Tba (cm/s). The measurements of brachial-ankle PWV, SBP, DBP, and heart rate were performed in the evening on the day before coronary angiography. In the case of patients with acute coronary syndrome, the measurements were performed before the follow-up coronary angiography, which was conducted one week after admission. Patients were in a supine position after a sufficient sedentary period. The validity and reproducibility of such brachial-ankle PWV measurements have been described elsewhere (17, 19) . The higher brachial-ankle PWV values measured on either side of each patient was used for the analysis.
Coronary Angiography
Coronary angiography was performed by the Judkins technique (23) . Coronary arteries were opacified with 5-8 ml contrast medium and examined from various angles. Coronary angiograms were analyzed according to the 15-segment coding system of the American Heart Association (24). The percentage of luminal diameter stenosis was evaluated in each segment, and CAD was defined as the presence of a greater than 50% narrowing in diameter for each of the three main coronary vessels. A consensus of opinion was reached by three observers who visually assessed the coronary cineangiograms. These observers were blinded to the information regarding brachial-ankle PWV.
Statistical Analysis
Data are expressed as the mean SEM. Student's t-test was used to detect statistically significant results according to the hemodynamic data (age, SBP, DBP, pulse pressure, heart rate, brachial-ankle PWV) and cardiovascular risk factors (BMI, total cholesterol, plasma glucose, the presence or absence of hypertension, diabetes mellitus, hyperlipidemia, smoking, and chest pain). There was a significant difference between brachial-ankle PWV and the presence or absence of CAD only in male patients, as described in the Results section. We therefore performed a logistic regression analysis with subjects divided by gender. Multivariate logistic regression analysis was performed to assess the correlation between the presence or absence of CAD and the possible risk factors. Subgroups were established for each of the variables that were prognostic for the presence of CAD. An odds ratio was estimated for each prognostic variable by comparing the relative risk of CAD in each subgroup with that of an appropriate reference group. Values of p<0.05 were considered to indicate statistical significance. Statistical analysis was performed with Stata Statistical Software 7.0 and S plus 2000 (Data Analysis Product Division, MathSoft, Seattle, USA).
PWV as a Diagnostic Test
Receiver operating characteristics curves were plotted and used to calculate sensitivities, specificities, positive predictive values, and negative predictive values for the probability of CAD being present. This was performed at various cut-off probability values. Table 1 shows the baseline clinical characteristics of male and female patients divided according to the presence or absence of CAD. The sample compromised 77 male and 46 female patients. Among female patients, those without CAD tended to be pre-menopausal, but this trend did not reach the Values are mean SEM. CAD, coronary artery disease; M/F, male/female; n, number of subjects; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; HR, heart rate; baPWV, brachial-ankle pulse wave velocity. NS, non-significant; p< 0.05.
Results
Clinical Characteristics and Risk Factors
level of statistical significance. In both sexes, patients with CAD had a significantly higher frequency of chest pain and were significantly older than those without CAD. A significant difference in brachial-ankle PWV between patients with and without CAD was observed only in male patients ( p 0.001). No difference was detected in the absolute values of SBP, DBP, pulse pressure, heart rate, BMI, total cholesterol, or plasma glucose between patients with and those without CAD in either sex. The prevalences of various risk factors in patients with and without CAD are shown in Table 2 . Among males, diabetes mellitus and hyperlipidemia were more frequently present in patients with CAD, while the frequencies of hypertension and smoking were not significantly different between patients with and without CAD. Among females, on the other hand, hypertension showed significantly higher frequency in patients with CAD, but diabetes mellitus, hyperlipidemia, and smoking were not significantly different between patients with and those without CAD.
The distribution of drug treatment of patients with or without CAD is shown in Table 3 . Lipid-lowering agents were used more frequently in male patients with CAD. This could reflect the similar total cholesterol level in male patients with or without CAD. Nitrates were also used more frequently in patients with CAD across both sexes. Tables 1 and 2 , we performed a multivariate logistic regression analysis of age, brachial-ankle PWV, hypertension, diabetes mellitus, hyperlipidemia, and chest pain in both sexes. In male patients, brachial-ankle PWV, diabetes mellitus, hyperlipidemia, and chest pain showed a significant correlation with the presence of CAD, although age and hypertension did not exhibit a correlation (Table 4) . In female patients, on the other hand, there was no significant correlation between these factors and the presence of CAD (data not shown).
Multivariate Logistic Regression Analysis of Age and PWV
Based on the results of
PWV as a Diagnostic Test
In males, the cut-off value for the probability of CAD being present was determined as 0.5 with the following performance values: 76.7% sensitivity, 56.7% specificity, 71.7% positive predictive value (PPV), and 63.0% negative predic- tive value (NPV). Figure 1 shows the relationship between brachial-ankle PWV and the predicted probability of CAD in male patients divided into 4 groups (without diabetes mellitus and hyperlipidemia; with diabetes mellitus; with hyperlipidemia; and with diabetes mellitus and hyperlipidemia). In male patients without diabetes mellitus and hyperlipidemia, when the brachial-ankle PWV value was over 2,150 cm/s, the predicted probability of CAD was 80%. A similar predicted probability of CAD was encountered with a lower brachial-ankle PWV in patients with diabetes mellitus and/or hyperlipidemia-i.e., over 1,750 cm/s in patients with diabetes mellitus, over 1,600 cm/s in patients with hyperlipidemia, and over 1,250 cm/s in patients with both diabetes mellitus and hyperlipidemia.
Moreover, male patients with chest pain had higher predicted probability of CAD than male patients without chest pain (Fig. 2) . In the group of male patients with chest pain, the cut-off value for the probability of CAD being present was determined as 0.5 with the following performance values: 83.7% sensitivity, 73.3% specificity, 81.8% PPV, and 75.9% NPV. 
Discussion
Clinical Implications of an Elevated Brachial-Ankle PWV
In the present study, we used brachial-ankle PWV as a marker of aortic stiffness. There have been several previous crosssectional studies focusing on brachial-ankle PWV. Nakamura et al. reported that brachial-ankle PWV is useful for estimating aortic damage (25) . Munakata et al. reported that brachial-ankle PWV may be a useful measure for arterial stiffness (19) . Furthermore, Yamashina et al. also reported that brachial-ankle PWV can be considered an acceptable marker with an efficacy comparable to that of carotidfemoral PWV (17) . Cortez-Cooper et al. reported the accuracy and the variability of this automatic device for measuring arterial stiffness and the ankle-brachial index (20) . PWV is composed of a central elastic arterial component and a peripheral muscular arterial component. The portion made up by the peripheral muscular arterial component is larger in brachial-ankle PWV than in carotid-femoral PWV. Because the PWV in the peripheral muscular arteries is greater than that in the central elastic arteries, the PWV values in the present study were higher than those in previous studies using the carotid-femoral PWV (6) (7) (8) . The method that we used to measure brachial-ankle PWV does not require any specialized technique, but rather measures brachial-ankle PWV automatically. Hemodynamic data and coronary risk factors such as blood pressure, pulse pressure, heart rate, total cholesterol, and plasma glucose were not significantly related to the presence of CAD in either sex. This may be explained by the fact that some of the patients with risk factors had been previously treated. In female patients, age, hypertension and chest pain were significantly related to the presence of CAD. However, those factors lost their significance in multivariate logistic regression analysis. In male patients, in contrast, brachial-ankle PWV and the presence of diabetes mellitus, hyperlipidemia, and chest pain were significantly correlated to CAD even in multivariate logistic regression analysis.
These results indicate that brachial-ankle PWV is an independent predictor of CAD in male patients, but not in female patients.
In male patients without risk factors, the prognostic ability of high brachial-ankle PWV (>2,150 cm/s) for the presence of CAD showed a sensitivity of 76.7%, specificity of 56.7%, and PPV of 71.7%. In male patients with risk factors such as diabetes mellitus and hyperlipidemia, on the other hand, lower brachial-ankle PWV than 2,150 cm/s showed the similar predicted probability of CAD. Furthermore, we found that male patients with history of chest pain have higher PPV (81.8%) for the presence of CAD than those without history of chest pain. These results suggest that, in men, it may be necessary to perform a non-invasive study such as a treadmill stress test or myocardial scintigraphy when a high value of brachial-ankle PWV, especially accompanied with diabetes mellitus and/or hyperlipidemia, and history of chest pain are documented. However, the indication of CAG is decided based on the clinical course of patients, including the history of chest pain and electrocardiographic and echocardiographic findings. We must recognize that the values of brachial-ankle PWV constitute important information for the predictive prevalence of coronary artery disease.
Study Limitations
The present study examined only patients suffering from heart disease, and thus the results cannot be extrapolated to the general population. Also, the prognosis of patients cannot be assessed, because this study was cross-sectional in nature. A further longitudinal study will thus be needed. Nevertheless, the present study shows that the direct measurement of arterial stiffness by this simple method may be of great help for the evaluation of the risk of CAD, at least in men.
In accordance with their heart disease status, all patients were taking a variety of medications. Thus, it remains a question whether or not medications influenced the data of brachial-ankle PWV. It has been reported that vasoactive drugs, including nitrates, produced a significant decrease in carotid-femoral PWV in healthy men (26) , and that lipidlowering agents, simvastatin improved peripheral PWV (27) . Furthermore, the angiotensin converting enzyme-inhibitor, captopril, and β-blocker, propranolol, effectively reduced carotid-femoral PWV in healthy subjects (28) . In our study, we found that treatments with nitrates and lipid-lowering agents were more frequent in male patients with CAD, but patients who had been taking these agents showed a higher brachial-ankle PWV. These results indicate that the medication did not have a major effect on the values of brachial-ankle PWV in this study.
In female patients, there was no significant correlation between brachial-ankle PWV and the presence of CAD. This might have been due to the small number of female patients suffering from CAD. Also, this study employed both preand post-menopausal women. It has been reported that carotid-femoral PWV is higher in post-menopausal women than in age-and blood pressure-matched pre-menopausal women (29, 30) . Moreover, in a previous study, menopause seemed to be the crucial phenomenon explaining the augmented increase of brachial-ankle PWV with aging in females (31) . In our study, brachial-ankle PWV in female patients without CAD was higher than that in male patients without CAD. This may have been related to the fact that the prevalence of risk factors such as hyperlipidemia and diabetes mellitus were even higher in female patients without CAD than in male patients without CAD. Further studies employing a greater number of female patients will be needed to fully investigate the influence of gender on the relationship between brachial-ankle PWV and coronary artery disease. It would also be useful to separate pre-and postmenopausal females.
In conclusion, the present cross-sectional study has shown that for male patients, increased brachial-ankle PWV, as well as diabetes mellitus and hyperlipidemia, was significantly and independently associated with the presence of CAD. In male patients even without diabetes mellitus and hyperlipidemia, high brachial-ankle PWV appeared to be a good predictor of the presence of CAD. Furthermore, we found that male patients with either of two risk factors, i.e., diabetes mellitus or hyperlipidemia, showed a similarly high predicted probability of having CAD with the lower values of brachial-ankle PWV.
